Introduction
============

Familial adenomatous polyposis syndrome (FAP) is a well-known autosomal-dominant inherited disease caused by a germline mutation in the *adenomatous polyposis coli* (APC) tumor suppressor gene on chromosome 5q21 [@JR216-1]. The estimated prevalence of this syndrome is between 1 in 5000 and 1 in 8000 [@JR216-2]. Currently, all patients with FAP and their family members who carry the APC gene are scheduled for prophylactic total colectomy before the development of colon cancer [@JR216-3]. Following that protocol, the mortality rate from colon cancer in these patients has been significantly decreased. Unfortunately, up to 80 % of patients with FAP still develop proximal small bowel polyps [@JR216-4] [@JR216-5]. In this subgroup, the incidence of duodenal cancer including ampullary cancers varies from 3 % to 12 % [@JR216-6]. Endoscopic surveillance with end-view and side-view duodenoscopy is recommended for patients with FAP, with the interval between endoscopies varying from every 6 months to 5 years, depending on the character of the upper gastrointestinal polyps. Unfortunately, the technique is generally based on white light endoscopy (WLE) and the efficacy of the recommendation for endoscopy has never been confirmed [@JR216-7].

In the past 10 years, many instruments including narrow band imaging (NBI) and probe-based confocal laser endomicroscopy (pCLE), have been developed to distinguish between adenoma and nonadenoma lesions in certain gastrointestinal areas, including the ampulla and surrounding area [@JR216-8] [@JR216-9] [@JR216-10]. Unlike the previous version of the magnifying NBI endoscope, which was available only at certain endoscopic centers that focused more on research, the new dual focus NBI endoscope (dNBI) is now commercially available to community practitioners in both a 100 and 200 series. This study was designed to compare the value of using dNBI and pCLE to screen ampullary and nonampullary polyps for adenoma.

Patients and methods
====================

Between December 2012 and November 2013, 26 consecutive patients previously diagnosed with FAP at the King Chulalongkorn Memorial Hospital were recruited. Male and female patients aged 18 years or older with a history of FAP and who were able to provide written informed consent were eligible. Exclusion criteria were evidence of coagulopathy (INR ≥ 1.5 and/or platelet \< 80 000, other bleeding tendency precluding biopsy, pregnancy, and allergy to fluorescein sodium. The primary outcome was definition of the diagnostic values of dNBI and pCLE for duodenal adenoma differentiation. The secondary outcome was exploration of new imaging findings for adenoma by dNBI and pCLE. The study protocol and consent forms were approved by the Chulalongkorn University Institutional Review Board (No. 440/55) and ClinicalTrials.gov (NCT02162173).

Instrument
----------

An end-viewing high-definition white light endoscope (HWE) with dual focus NBI function (dNBI) (GIF-HQ 190, Olympus, Tokyo, Japan) was attached with a transparent cap (D-201-118044, Olympus, Tokyo, Japan) for detailed examination. dNBI mode was applied for real-time histology assessment. Real-time histology assessment with a confocal laser system was performed using a GastroFlex probe (pCLE, Mauna Kea Technologies, Paris, France).

Endoscopic procedure and criteria for adenoma diagnosis
-------------------------------------------------------

Endoscopic diagnostic criteria for differentiating between adenoma and nonadenoma were adopted from the previous studies by Uchiyama Y et al. [@JR216-11] The criteria for diagnosis of nonadenomatous lesions were normal or oval-shaped villi with regular vascular structures demonstrated by dNBI ( [Fig. 1 a](#FI216-1){ref-type="fig"}) and normal epithelium border with regular capillary pattern demonstrated by pCLE ([Fig. 2 a](#FI216-2){ref-type="fig"}). The criteria for diagnosis of adenoma by dNBI was either pinecone or leaf-shaped villi (called "white villi" in this study and a term also used by another investigator [@JR216-12]) with or without dilated or tortuous capillary ( [Fig. 1 b](#FI216-1){ref-type="fig"}). The criteria for diagnosis adenoma by pCLE were dark, irregular, and nonstructural mucosa with or without abnormal capillary networks ([Fig. 2 b](#FI216-2){ref-type="fig"}). A real-time adenoma diagnosis was made by the two independent endoscopists (BI and RP) experienced with dNBI and pCLE readings. Prior to participating in the study, they had experience in reviewing images obtained with dNBI and pCLE and had published related results elsewhere [@JR216-13] [@JR216-14] [@JR216-15].

![ The dNBI findings of 1) normal; normal or oval-shaped villi with regular vascular structures (**a**) and 2) adenoma; pinecone and/or leaf-shaped villi with dilated and tortuous vessels (**b**).](10-1055-s-0034-1392235-i216ei1){#FI216-1}

![ The pCLE findings of 1) normal: normal epithelium border (long arrow) with regular capillary pattern (short arrow) (**a**) and 2) adenoma: dark/irregular epithelium (long arrow) with tortuous capillary networks (short arrow) (**b**).](10-1055-s-0034-1392235-i216ei2){#FI216-2}

During the study period, all 26 patients underwent the procedure under conscious sedation with intravenous midazolam and meperidine. Before the procedure, 10 mg of hyoscine was administered to decrease intestinal peristalsis. At the beginning of the procedure, the first endoscopist (BI) used an end-viewing high-definition white light endoscope attached to an endoscopic cap to examine the first and second part of the duodenum. The cap was used to facilitate a proper enface view of the ampulla and surrounding area ([Fig. 1 a](#FI216-1){ref-type="fig"}). All applicable ampullary and nonampullary (duodenal) polyps larger than 1 mm were examined in this study. The dNBI mode then was switched on for real-time diagnosis by the first endoscopist (BI). Subsequently, the second endoscopist (RP), who was blinded to the NBI reading, was called from another room to perform pCLE examination. During pCLE evaluatiom, 2.5 mL of 10 % fluorescein (Novartis Pharmaceutical Corporation, Bangkok, Thailand) was injected. In the case of multiple nonampullary lesions, the first endoscopist only examined the lesions with pCLE but did not inform the second endoscopist about the result of the dNBI readings. Polypectomy was then performed by the second endoscopist. The duration of the entire procedure and all complications related to the procedures were recorded.

Histological assessment
-----------------------

All polypectomy specimens were immersed in formalin and sent for histological examination. The specimens were stained with hematoxylin and eosin (H&E) and reviewed by an experienced gastrointestinal pathologist (NW) blinded to the endoscopic diagnosis. Definitive diagnosis was based on the Vienna classification[@JR216-16] for differentiation between adenoma and non-adenoma.

Interobserver agreement
-----------------------

Two endoscopists (BI and RP) interpreted all of the off-line dNBI and pLE images from this study to evaluate for interobserver agreement.

Statistical Analysis
--------------------

By using histology as the gold standard, the diagnostic values of dNBI and pCLE for ampullary and non-ampullary polyp interpretation were assessed for sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy. For numerical variables, the results were expressed as a mean ± SD, whereas other quantitative variables were expressed as percentages. Cohen's kappa (κ) was used to analyze interobserver agreement. The value of kappa (κ) for agreement was graded as slight agreement for 0.01 to 0.20, fair for 0.21 to 0.40, moderate for 0.41 to 0.60, substantial for 0.61 to 0.80, and almost perfect for 0.81 to 1.00. SPSS version 17.0 (SPSS (Thailand) Co., Ltd., Bangkok, Thailand) for Windows was used for statistical analysis.

Results
=======

A total of 57 images were obtained from 27 patients. The mean age of patients with FAP was 38.9 ±12.2 years and most were female (77.8 %). The average age at diagnosis of FAP was 31.8±13.0 years (10 -- 56). Of the patients, 26 of 27 (96.3 %) underwent colectomy at a mean age of 32.4 years and seven (25.9 %) already harbored adenocarcinoma in the surgical specimen. One 19-year-old female has been scheduled for a prophylactic colectomy in a year. Eighteen of 27 (66.7 %) had a family history of FAP ([Table 1](#TB216-1){ref-type="table"}).

###### Patient, disease, and procedure characteristics

  Patient and disease characteristics (N = 27)                Number (%)
  ----------------------------------------------------------- ----------------------
  Age (mean± SD), years                                       38.9 ± 12.2
  Gender, male                                                6 (22.2)
  Age of FAP diagnosis (mean± SD), (max,min), years           31.8 ± 13.0, (10,56)
  History of colectomy                                        26 (96.3)
  Age at colectomy(mean± SD),(max,min) years                  32.5 ± 12.7, (15,56)
  Colon cancer                                                7 (25.9)
  Age at colon cancer diagnosis (mean± SD), (max,min) years   38.3 ± 11.1 (24,51)
  Family history of FAP                                       18 (66.7)

One patient was excluded from the study on the day of examination because she refused to have a biopsy, although she underwent the full spectrum of endoscopic examination. Another two refused fluorescein injection and they were recruited only for the dNBI part. Ultimately, there were 55 matched biopsies (25 ampullas and 30 nonampullas) with 55 dNBI readings and 53 pCLE readings. Completion of a dNBI examination required 17.0 ± 7.6 min, whereas pCLE required 12.3 ± 6.7 min. The mean size of ampullary and nonampullary polyps was 2.6±3.3 mm and 2.2±4.5 mm, respectively. Of those 55 lesions, the number of ampullary and nonampullary adenoma diagnosed with dNBI, pCLE, and histology were 36 (65 %), 34 (64 %), and 32 (58 %), respectively. For the primary outcome, the overall sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of dNBI vs. pCLE were 96.9 % vs. 93.8 %, 78.3 % vs. 81 %, 86.1 % vs. 88.2 %, 94.7 vs. 89.5 %, and 92.4 % vs. 88.6 %, respectively, using histology as the gold standard ([Table 2](#TB216-2){ref-type="table"}).

###### Diagnostic values of dual focus narrow band imaging and probe-based confocal laser endomicroscopy in FAP-related duodenal adenoma

  Location with method (N)                                          Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)   Accuracy (%)   False negative (%)
  ----------------------------------------------------------------- ----------------- ----------------- --------- --------- -------------- --------------------
  Ampulla with dNBI (25)                                            91.7              92.3              91.7      92.3      92             8.3
  Ampulla with pCLE (23)[1](#FN216-1){ref-type="table-fn"}          91.7              90.9              91.7      90.9      91.3           8.3
  Non-ampullary polyp with dNBI (30)                                100               60                83.3      100       92.8           0
  Non-ampullary polyp with pCLE (30)                                95                70                86.3      87.5      86.6           5
  Both locations with dNBI (55)                                     96.9              78.3              86.1      94.7      92.4           3.1
  Both locations with pCLE (53)[1](#FN216-1){ref-type="table-fn"}   93.8              81                88.2      89.5      88.6           6.2

dNBI, dual focus narrow band imaging; pCLE, probe-based confocal laser endomicroscopy.

In two cases, pCLE was not used because of lack of patient consent.

Both dNBI and pCLE were 100 % accurate for all stages of the Spigelman classification, with the exception of stage IV because no patients enrolled had a stage IV polyp ([Table 3](#TB216-3){ref-type="table"}).

###### Accuracy of dNBI and pCLE according to Spigelman classification

                        Number of patients (%)   Accuracy by dNBI   Accuracy by pCLE
  --------------------- ------------------------ ------------------ ------------------
  Spigelman stage 0     9 (35 %)                 100 %              100 %
  Spigelman stage I     5 (19 %)                 100 %              100 %
  Spigelman stage II    6 (23 %)                 100 %              100 %
  Spigelman stage III   6 (23 %)                 100 %              100 %
  Spigelman stage IV    0                        NA                 NA

dNBI, dual focus narrow band imaging; pCLE, probe-based confocal laser endomicroscopy;

NA, no data.

Approximately 80 % of lesions with adenoma (27 of 32) met the criteria for whit villi. In addition, we found a new endoscopic feature for adenoma diagnosis in one patient who did not have white villi. In that individual, pCLE revealed dark, irregular, variable thickening of epithelial borders, which we termed "bumpy." The "bumpy" criterion was 100 % accurate for diagnosis of adenoma in all five lesions with those characteristics.

The interobserver agreement for dNBI readings was rated as substantial (Kappa 0.78) and that for pCLE was almost perfect (Kappa 0.95).

Discussion
==========

Conventional WLE may be optimal for duodenal polyp detection but it is considered suboptimal for characterization [@JR216-17]. In the current series, 23/55 (42 %) polyps were confirmed by histology as nonadenoma, making it a potentially useful technique for characterizing lesions. Risk associated with removal of duodenal polyps is significant [@JR216-18] and removal of nonadenomatous polyps is definitely unnecessary. In addition, performance of random biopsies has been shown to have varying accuracy for adenoma diagnosis (40 -- 85 %) [@JR216-19] [@JR216-20] [@JR216-21] [@JR216-22]. Conventional chromoendoscopy also has been attempted to improve the yield for duodenal polyp detection [@JR216-17] [@JR216-23] [@JR216-24]. Kiesslich R, et al. reported improved outcome with indigocarmine chromoendoscopy than with WLE (98 vs. 28 lesions; *P* = 0.0042) for detection of duodenal abnormality in 118 patients [@JR216-23]. Unfortunately, the dye spray technique is cumbersome and only helpful for screening a suspicious lesion, and targeted biopsy is still required to confirm histology.

In recent years, digital chromoendoscopy including NBI has been introduced for duodenal polyp evaluation. In 2006, based on experience in 14 patients with FAP who underwent surveillance upper gastrointestinal endoscopy, Uchiyama Y et al. [@JR216-11] published the endoscopic patterns of ampullary polyps under NBI, which were classified as I, oval-shaped villi; II, pinecone/leaf-shaped villi (called "white villi" in this study); or III, irregular/nonstructured villi. An excellent correlation (100 %) was demonstrated between patterns II and III and the histology of adenoma and adenocarcinoma. However, the three criteria have yet to be validated in any subsequent study. Using different criteria, Shahid et al. adopted the dysplastic Barrett features read by NBI and pCLE as their means of diagnosing duodenal adenoma [@JR216-25]. In their study, they compared the efficacy of non-magnifying NBI and pCLE for diagnosis of adenoma in 65 gastric and duodenal polyps [@JR216-25]. They showed a trend toward superior efficacy in diagnosis of gastric and duodenal adenoma for pCLE compared with non-magnifying NBI (*P* = 0.8), (sensitivity 92 % vs. 83 %, specificity 78 % vs. 78 %, PPV 71 % vs. 69 %, NPV 94 % vs. 89 % and accuracy 83 % vs. 80 %) [@JR216-24] With the improvement in image quality plus dual focus function of the new NBI, the current study demonstrated much higher efficacy for dNBI in diagnosis of duodenal adenoma compare to conventional NBI. However, the efficacy of our pCLE readings was good and in keeping with those reported in the previous study [@JR216-25]. In addition, the current series contained only duodenal adenoma (not other lesions).

In our experience, because of enhancement of the vessels in the lamina propria (seen as deep blue color) with dNBI, we observed better delineation of both villi and vascular patterns. Moreover, the white villi with well-demarcated borders were better appreciated with dNBI. Apart from the better quality of the new NBI, we speculate that the higher efficacy of our NBI readings may be related to the more specific criteria for duodenal adenoma that we used [@JR216-12]. On the other hand, the pCLE images of adenoma that showed dark, irregular, and nonstructural mucosa and sometimes abnormal capillary networks corresponded well to the histology of adenoma, which typically contains elongated, stratified columnar cells with increased nuclear-cytoplasmic ratio, known as "atypical columnar cells" ( [Fig. 3](#FI216-3){ref-type="fig"}).

![The corresponding adenoma finding from pCLE and pathological image](10-1055-s-0034-1392235-i216ei3){#FI216-3}

In the current series, dNBI and pCLE demonstrated lower specificity for adenoma in nonampullary than in ampullary lesions (65 % vs. 91 %). We found that the pattern of white villi could also be seen in non-neoplastic duodenal polyps, whereas the ampulla hardly contains non-neoplastic white villi. The white villi are believed to be lipid droplets which have substantially accumulated within the enterocytes [@JR216-26]. No supporting data yet exist to explain the mechanism of lipid accumulation in duodenal adenoma or how to differentiate them from non-neoplastic mucosa. However, we observed that the majority of neoplastic white villi appeared denser than non-neoplastic white villi ([Fig. 4](#FI216-4){ref-type="fig"}). Unfortunately, because all patterns of white villi were defined as adenoma in this study, false-positive readings may occur in some non-neoplastic lesions with white villi. On the other hand, a false-negative reading in a small duodenal adenoma also may occur if the pCLE probe (diameter 2.3 mm) is misplaced in nearby normal mucosa. In our experience, false-negative diagnosis by pCLE sometimes occurs in polyps smaller than 2.5 mm.

![partial rim of white villi under white light represented non-adenoma (blue circle), **b** dense white villi under dNBI represented adenoma.](10-1055-s-0034-1392235-i216ei4){#FI216-4}

Spigelman classification [@JR216-7] can sort the risk of duodenal adenoma development and has been used to guide the frequency of upper endoscopic surveillance in FAP patients. This classification takes into consideration the number and size of polyps, and polyp histology [@JR216-5]. Unfortunately, in many studies, the scheduled surveillance protocol according to the Spigelman classification has been shown not to prevent development of unresectable ampullary cancer [@JR216-27] [@JR216-28]. A modified Spigelman classification, which omits moderate dysplasia from pathologic score, recently has been introduced, with the aim of reducing the difficulty of pathology reading but it yet to be validated. It also does not include ampullary adenoma, which is associated with the highest risk of development of cancer. Moreover, polyp histology is still required for staging. In the current, study without the need for polyp histology, we found perfect (100 %) concordance between real-time histological readings (either dNBI or pCLE) and the standard Spigelman classification (only in stage 0-III) ([Table 3](#TB216-3){ref-type="table"}).

Hypothetically, pCLE may be able to distinguish between the histologies of tubular adenoma (TA), tubulovillous adenoma (TVA), and villous adenoma (VA). Unfortunately, all specimens in the current study were confirmed by pathology as TA without TVA or VA and graded as Spigelman stage 0 -- III without stage IV by pCLE. The results can only be used to read Spigelman stage 0 to III polyps containing TA and it did not address the importance of histological differentiation between TA, TVA, and VA by pCLE. Therefore, before we can introduce this into standard practice, we need to validate this protocol in a larger FAP population that includes Spigelman stage IV and TVA/VA.

The high NPV in both diagnosis and characterization of the lesion, however, supports the excellent efficacy of a new instrument [@JR216-29]. The NPV of dNBI was more than 90 % for both ampullary and nonampullary adenoma interpretation whereas the NPV for pCLE was more than 90 % for only ampullary adenoma interpretation. Although the NPV for CLE in nonampullary adenoma readings did not reach 90 %, it was 88 %. In addition, the PPVs of dNBI and pCLE were high and acceptable for both ampullary and nonampullary adenomas (83 % -- 92 %) ( [Table 2](#TB216-2){ref-type="table"}). The adenoma detectedin the current study was indeed an adenoma and not a lesion of "lesser pathology," such as Brunner's gland hyperplasia or a lesion of benign duodenal histology. Thus unnecessary endoscopic resection was not an issue. Moreover, we demonstrated a low rate of false negatives across all categories of lesions (0 % -- 8 %) ([Table  2](#TB216-2){ref-type="table"}). To translate this protocol into practice, we may use either dNBI or pCLE for the diagnosis of both ampulla and nonampullary duodenal polyps. That practice may save time both on examination during upper gastrointestinal surveillance and perhaps on the cost of polyp specimen assessment if dNBI is used.

We also identified a "bumpy lesion" as another representative finding of nonampullary adenoma. This lesion has been mentioned in a recent Japanese review article as nodular protrusion [@JR216-30]. It can be easily identified under either HWE or dNBI, whereas on pCLE, findings for a bumpy lesion were similar to those for non-bumpy adenoma. Although a bumpy characteristic was found in only one patient, that patient had 5 such lesions, all of which were confirmed as adenoma by histology.

The main limitation of our study is the number of patients with FAP who presented for an upper gastrointestinal endoscopy surveillance. For this series, we were able to recruit only 27 patients with FAP and was no high-grade dysplasia was documented. Therefore, we were unable to demonstrate the benefit of dNBI and pCLE in grading of dysplasia. Moreover, the number of patients was not sufficient to perform a randomized controlled trial for a direct comparison between dNBI and pCLE. However, instead of using patient numbers we used the number of duodenal polyps and ampulla as the representative population in this study (n = 55), which helped us to calculate the statistical significance of the sensitivity, specificity, PPV, NPV, and accuracy between the two different methods. Another limitation is that the skills on pCLE and dNBI readings of the two endoscopists have never been compared directly with a crossover design. However, all photos and video clips from these two modalities were recorded and internally audited by the two endoscopists. The interobserver agreements in dNBI and pCLE interpretation between them were excellent (kappa 0.78 -- 0.95). Moreover, this study definitively lacks a third arm with white light recognition of adenoma versus nonadenomatous lesions. A further study should include white light mode in the protocol to demonstrate the efficacy of WLE for lesion detection and characterization. Finally, in this study, an end-viewing endoscope was used instead of a side-viewing scope because the dNBI function was not available on the side-viewing model during the study period.

Conclusions
===========

In conclusion, dNBI and pCLE are both useful for real-time adenoma reading in patients with FAP who present for upper gastrointestinal endoscopy surveillance. Both methods achieved NPVs of more than 90 %. Practically, dNBI is a more reasonable method, considering the high cost of pCLE. Real-time histology may replace standard histology in patients with FAP, especially those with Spigelman stage 0 -- III lesions.
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